Affinity Asset Advisors LLC Buys 54,863 Shares of Establishment Labs Holdings Inc. $ESTA

Affinity Asset Advisors LLC raised its stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 19.6% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 334,863 shares of the company’s stock after purchasing an additional 54,863 shares during the quarter. Establishment Labs makes up about 2.0% of Affinity Asset Advisors LLC’s portfolio, making the stock its 14th biggest holding. Affinity Asset Advisors LLC owned 1.16% of Establishment Labs worth $14,302,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Geode Capital Management LLC boosted its holdings in shares of Establishment Labs by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 25,917 shares of the company’s stock valued at $1,105,000 after buying an additional 299 shares during the last quarter. Patriot Financial Group Insurance Agency LLC increased its holdings in Establishment Labs by 5.2% during the second quarter. Patriot Financial Group Insurance Agency LLC now owns 6,025 shares of the company’s stock worth $257,000 after buying an additional 300 shares during the last quarter. Raymond James Financial Inc. raised its position in Establishment Labs by 0.4% during the first quarter. Raymond James Financial Inc. now owns 119,752 shares of the company’s stock worth $4,886,000 after acquiring an additional 491 shares in the last quarter. Swiss National Bank lifted its stake in Establishment Labs by 1.3% in the first quarter. Swiss National Bank now owns 39,000 shares of the company’s stock valued at $1,591,000 after acquiring an additional 500 shares during the last quarter. Finally, CWM LLC lifted its stake in Establishment Labs by 45.9% in the second quarter. CWM LLC now owns 2,182 shares of the company’s stock valued at $93,000 after acquiring an additional 686 shares during the last quarter. Institutional investors own 72.91% of the company’s stock.

Establishment Labs Stock Up 0.0%

ESTA opened at $70.73 on Friday. The stock has a fifty day moving average of $55.33 and a 200-day moving average of $45.20. The company has a market capitalization of $2.06 billion, a P/E ratio of -24.90 and a beta of 1.01. Establishment Labs Holdings Inc. has a fifty-two week low of $26.56 and a fifty-two week high of $73.19. The company has a debt-to-equity ratio of 15.06, a quick ratio of 2.10 and a current ratio of 3.33.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings results on Wednesday, November 5th. The company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.54) by $0.16. The business had revenue of $53.78 million for the quarter, compared to analyst estimates of $52.28 million. Establishment Labs had a negative net margin of 43.45% and a negative return on equity of 235.45%. Establishment Labs’s revenue for the quarter was up 33.8% compared to the same quarter last year. During the same period last year, the firm earned ($0.59) earnings per share. On average, equities analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Establishment Labs from $45.00 to $71.00 and gave the stock an “overweight” rating in a research note on Thursday, November 6th. Mizuho lifted their price target on Establishment Labs from $70.00 to $85.00 and gave the stock an “outperform” rating in a report on Thursday, November 6th. Wall Street Zen upgraded Establishment Labs from a “sell” rating to a “hold” rating in a research note on Sunday, October 19th. Citigroup reissued a “neutral” rating on shares of Establishment Labs in a report on Tuesday, October 7th. Finally, BTIG Research raised their price target on Establishment Labs from $70.00 to $81.00 and gave the company a “buy” rating in a report on Friday, November 14th. Six analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Establishment Labs currently has a consensus rating of “Moderate Buy” and a consensus target price of $68.29.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.